An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough

Rayid Abdulqawi, Imran Satia, Kimberley J Holt, Rachel Dockry, Shilpi Sen, Jaclyn A Smith

Research output: Contribution to journalLetterpeer-review

Abstract

Blocking NMDA receptors with memantine in refractory chronic cough patients is poorly tolerated and demonstrates no improvement in cough https://bit.ly/3kgx2g1.

Original languageEnglish
Article number00447-2021
JournalERJ Open Research
Volume7
Issue number3
DOIs
Publication statusPublished - 29 Jul 2021

Fingerprint

Dive into the research topics of 'An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough'. Together they form a unique fingerprint.

Cite this